Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Pharmacokinetics and Biodistribution Study of 7A7 Anti-Mouse Epidermal Growth Factor Receptor Monoclonal Antibody and Its F(ab')(2) Fragment in an Immunocompetent Mouse Model.

Rabasa Capote A, González JE, Rodríguez-Vera L, López A, Sánchez Ramírez B, Garrido Hidalgo G.

ISRN Pharmacol. 2012;2012:417515. doi: 10.5402/2012/417515. Epub 2012 Nov 21.

2.

Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.

Garrido G, Rabasa A, Sánchez B, López MV, Blanco R, López A, Hernández DR, Pérez R, Fernández LE.

J Immunol. 2011 Nov 15;187(10):4954-66. doi: 10.4049/jimmunol.1003477. Epub 2011 Oct 7.

4.

Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.

Burvenich IJ, Schoonooghe S, Blanckaert P, Bacher K, Vervoort L, Coene E, Mertens N, De Vos F, Slegers G.

Nucl Med Biol. 2007 Apr;34(3):257-65.

PMID:
17383575
5.

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody.

Negri DR, Tosi E, Valota O, Ferrini S, Cambiaggi A, Sforzini S, Silvani A, Ruffini PA, Colnaghi MI, Canevari S.

Br J Cancer. 1995 Oct;72(4):928-33.

6.

T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies.

Garrido G, Lorenzano P, Sánchez B, Beausoleil I, Alonso DF, Pérez R, Fernández LE.

Cancer Immunol Immunother. 2007 Nov;56(11):1701-10. Epub 2007 Apr 6.

PMID:
17415565
8.

OKT3 F(ab')2 fragments--retention of the immunosuppressive properties of whole antibody with marked reduction in T cell activation and lymphokine release.

Woodle ES, Thistlethwaite JR, Ghobrial IA, Jolliffe LK, Stuart FP, Bluestone JA.

Transplantation. 1991 Aug;52(2):354-60.

PMID:
1908148
10.
11.
14.

Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism.

Rogers BE, Anderson CJ, Connett JM, Guo LW, Edwards WB, Sherman EL, Zinn KR, Welch MJ.

Bioconjug Chem. 1996 Jul-Aug;7(4):511-22.

PMID:
8853465
15.

Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.

Colapinto EV, Humphrey PA, Zalutsky MR, Groothuis DR, Friedman HS, de Tribolet N, Carrel S, Bigner DD.

Cancer Res. 1988 Oct 15;48(20):5701-7.

16.

Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancer.

de Bree R, Roos JC, Quak JJ, den Hollander W, Wilhelm AJ, van Lingen A, Snow GB, Dongen GA.

Clin Cancer Res. 1995 Mar;1(3):277-86.

19.

Labeling monoclonal antibodies and F(ab')2 fragments with (111In) indium using cyclic DTPA anhydride and their in vivo behavior in mice bearing human tumor xenografts.

Powe J, Pak KY, Paik CH, Steplewski Z, Ebbert MA, Herlyn D, Ernst C, Alavi A, Eckelman WC, Reba RC, et al.

Cancer Drug Deliv. 1984;1(2):125-35.

PMID:
6544629
20.

Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.

Holton OD 3rd, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN.

J Immunol. 1987 Nov 1;139(9):3041-9.

PMID:
3499463
Items per page

Supplemental Content

Write to the Help Desk